C12Y 201/02003
Phosphoribosylaminoimidazolecarboxamide formyltransferase , i.e. aicar formyltransferase
Official title: Phosphoribosylaminoimidazolecarboxamide formyltransferase (2.1.2.3), i.e. AICAR formyltransferase
C12Y201/02003 (Phosphoribosylaminoimidazolecarboxamide formyltransferase , i.e. aicar formyltransferase) appears on 1 US grants and 3 published applications in this corpus.
Search patents in C12Y- Granted patents
- 1
- Published applications
- 3
- Assignees
- 3
- Inventors
- 14
- Latest grant
- 8 Dec 2020
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2007 | 0 | 1 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 2 |
| 2019 | 0 | 0 |
| 2020 | 1 | 0 |
By publication year.
Recent patents
- Method for Producing Objective Substance22 Nov 2018US 2018/0334693 A1Ajinomoto Co., Inc.
- Multilamellar lipid vesicle compositions including a conjugated anaplastic lymphoma kinase (alk) variant and uses thereof4 Jan 2018US 2018/0000906 A1Vedantra Pharmaceuticals, Inc.
- Modulation of endogenous AICAR levels for the treatment of diabetes and obesity18 Jan 2007US 2007/0015720 A1CytRx Corporation
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.